Sign in

Nitin Jain

@nitinjainmd.bsky.social
195 followers 13 following 6 posts

Professor, Department of Leukemia, MD Anderson Cancer Center

PostsRepliesMedia
Reposted by Nitin Jain
Hagop Kantarjian, M.D. @drhkantarjian.bsky.social · 24/02/2025
Treatment-free remission in non-transplanted Ph+ #ALL pts is feasible in carefully selected pts. Those in CR1 (n=6) who maintained CMR for >48 mos did not relapse following TKI discontinuation. @mdanderson.bsky.social doi.org/10.1002/cncr... @nitinjainmd.bsky.social @niranjankhaire.bsky.social
052
Reposted by Nitin Jain
VJHemOnc @vjhemonc.bsky.social · 03/02/2025
In an interview from #ASH24, @nitinjainmd.bsky.social of @mdanderson.bsky.social discusses an analysis assessing the safety of discontinuing TKIs in patients with Ph+ ALL not undergoing alloSCT. Click here to watch: 👉 buff.ly/4hqSeue 👈 #ALLsm #Leusm #Leukemia #HemOnc
041
Nitin Jain @nitinjainmd.bsky.social · 20/12/2024
As we have increasing Rx options in Firstline #CLL including new updates from #ASH24, here is a summary slide I made for PFS in selected trials by IGHV status caveat: cross trial comparison but still helpful as we look across trials #CLL #leusm @MDAndersonNews @ASH_hematology
070
Nitin Jain @nitinjainmd.bsky.social · 09/12/2024
Great fun last night at Bollywood themed ASH President’s reception
050
Reposted by Nitin Jain
Anand Patel @anand-88-patel.bsky.social · 06/12/2024
Ready to get things started at #ASH24! @nitinjainmd.bsky.social
1161
Nitin Jain @nitinjainmd.bsky.social · 05/12/2024
👉👉👉 #ASH24 TFR (Treatment free remission) is a well established concept in CP CML. But can you do TFR in Ph+ ALL in CR1 among pts who don’t undergo allo-SCT? 👉14 pt retrospective series at #ASH24 Please see us at the poster on Saturday in San Diego. Work led by Drs Kugler and Khaire
030
Nitin Jain @nitinjainmd.bsky.social · 29/11/2024
Stargazing in Joshua Tree National Park on Thanksgiving night
040
Nitin Jain @nitinjainmd.bsky.social · 25/11/2024
How was your weekend??!!
040